nav-left cat-right
cat-right

Astellas and REGiMMUNE to Collaborate on New Vacci...

TOKYO and MOUNTAIN VIEW, CA–(Marketwire – July 22, 2009) – REGiMMUNE Corporation today announced that Astellas Pharma Inc. and REGiMMUNE have entered into a collaboration agreement to jointly research and develop a novel vaccine-platform technology. The partnership will combine Astellas’ broad range of capabilities in screening and developing natural source-derived compounds with REGiMMUNE’s...

AEterna Zentaris Presents Two Posters on its PI3K ...

In Vitro and In Vivo Data Show AEZS-126 as Promising Oral Compound for Future Clinical Development in Cancer QUEBEC CITY, April 21 /PRNewswire-FirstCall/ – AEterna Zentaris Inc. (TSX: AEZ; NASDAQ: AEZS), a global biopharmaceutical company focused on endocrine therapy and oncology, today presented two posters on AEZS-126, a promising compound for clinical intervention of the PI3K/ Akt pathway in human tumors. The...

Ligand and GlaxoSmithKline Collaboration Identifie...

SAN DIEGO, Mar 30, 2009 (BUSINESS WIRE) —-Ligand Pharmaceuticals Incorporated (NASDAQ: LGND: 2.98, -0.14, -4.49%) today announced that it has identified a new lead for advancement in its alliance with GlaxoSmithKline (NYSE:GSK). This newly identified lead compound is from a program being evaluated as a potential treatment for inflammatory indications identified through the collaboration. As a result of...

Ligand and GlaxoSmithKline Collaboration Identifie...

SAN DIEGO, Mar 30, 2009 (BUSINESS WIRE) —-Ligand Pharmaceuticals Incorporated (NASDAQ: LGND: 2.98, -0.14, -4.49%) today announced that it has identified a new lead for advancement in its alliance with GlaxoSmithKline (NYSE:GSK). This newly identified lead compound is from a program being evaluated as a potential treatment for inflammatory indications identified through the collaboration. As a result...

New Model For Drug Discovery With Fluorescent Anes...

ScienceDaily (Apr. 8, 2009) — A collaboration of University of Pennsylvania and University of Wisconsin chemists and anesthesiologists have identified a fluorescent anesthetic compound that will assist researchers in obtaining more precise information about how anesthetics work in the body and will provide a means to more rapidly test new anesthetic compounds in the search for safer and more effective drugs. The study...

New Drug Shows Promise In Treating Drug-resistant ...

ScienceDaily (Apr. 11, 2009) — A new therapy for metastatic prostate cancer has shown considerable promise in early clinical trials involving patients whose disease has become resistant to current drugs. Chemists and biologists at UCLA and colleagues at several other institutions, including Memorial Sloan-Kettering Cancer Center, have created a new drug to treat a particularly lethal form of the disease, known as...
Page 10 of 31« First...89101112...2030...Last »